“I am excited to join OptiScan at this pivotal point in the company’s growth. I believe that the cutting-edge OptiScanner diagnostic system provides a unique platform to transform the way patients are managed in the ICU,” Vance, who led Hansen to an $80 million acquisition by Auris Health back in July 2016, said in prepared remarks. “I look forward to leveraging my experience in building and growing successful commercial organizations, as well as the current team’s deep technical insight and expertise, to maximize utility and value for patients, nurses, physicians and hospitals.”
“On behalf of the board of directors, I am pleased to welcome Cary to OptiScan,” added Paul Mieyal. “Cary’s proven ability to lead an organization as it leverages disruptive medical technologies, transforms existing markets, and establishes new standards will drive OptiScan’s commercialization strategy and activities in the global hospital market. Separately, the board would like to thank William Mince for his important strategic guidance and operational leadership during his tenure at OptiScan.” Read more
TrueVision Systems appointed Burton Tripathi as CEO, succeeding Forrest Fleming after 12 years in the corner office. Read more
- Strata Skin Sciences taps Hill for CFO
- Clinical Innovations appoints Behling as CFO
- Ex-St. Jude Medical CFO Zurbay fetches up at Patterson Cos.
- SetPoint Medical makes Shah marketing & commercialization senior director
- Globus Medical installs Gregoris as trauma VP
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.